Abrdn World Healthcare Fund (THW) Stock Price, News & Analysis

Company Overview

abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment fund focused on the global healthcare industry. The fund seeks to provide current income and long-term capital appreciation by investing primarily in equity and debt securities issued by companies involved in healthcare.

Its portfolio may include pharmaceutical and biotechnology companies, medical device and equipment manufacturers, healthcare services providers, diagnostics businesses, and other firms supporting the healthcare sector. The fund can invest across developed and emerging markets, giving shareholders exposure to healthcare companies in multiple geographic regions.

THW was launched in 2015 and was formerly known as Tekla World Healthcare Fund. It is managed by abrdn, a global investment company, and operates as a publicly traded closed-end fund rather than as an operating healthcare business.

Key Stats

• Today's Range: $12.95 to $13.24
• 50-Day Range: $11.92 to $14.18
• 52-Week Range: $11.18 to $14.50
• Volume: 162,550 shs
• Average Volume: 130,181 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 10.53%
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Record date for 9/30 Dividend: 9/22/2026
• Ex-Dividend for 9/30 Dividend: 9/22/2026
• Dividend Payable: 9/30/2026
• Record date for 10/30 Dividend: 10/23/2026
• Ex-Dividend for 10/30 Dividend: 10/23/2026
• Dividend Payable: 10/30/2026
• Today: 11/04/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Capital Markets
• Sub-Industry: Asset Management & Custody Banks
• Current Symbol: NYSE:THW
• CIK: 1635977
• Web: www.aberdeeninvestments.com
• Phone: (617) 772-8500
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $86.53 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A